Results about: tumour
Xavier Salvatella, ICREA researcher at IRB Barcelona, proposes a new approach to combat prostate tumour cells that have become unresponsive to the treatments currently available.
The incidence of prostate cancer is increasing worldwide. In the US and Europe, it is one of the most common tumours and among the main causes of death by cancer.
Part of the European Research Council’s reasoning for providing their coveted Starting Grants is to “provide top talent with good conditions at the right time to thrive.” For the team led by Fran Supek (b. Zagreb, Croatia, 1981), the right time has just arrived with the award of a Starting Grant worth 1.5 million euros of funding. His project, called HYPER-INSIGHT, was among the 13% of successful proposals of the 3,085 applications made to the 2017 ‘Starting Grants’ Call.
Researchers at IRB Barcelona reveal the capacity of epithelial-derived tumours to grow in the absence of a microenvironment.
Featured on the cover of the journal Proceedings of the National Academic of Sciences (PNAS), the study identifies the cell types and molecular mechanism involved in tumour initiation and growth.
The results of this study contribute to our understanding of the internal mechanisms of the tumour, which may provide a therapeutic target.